<DOC>
	<DOCNO>NCT02029573</DOCNO>
	<brief_summary>The purpose study explore efficacy safety Atorvastatin combination multimodality therapy concurrent radiotherapy plus temozolomide follow adjuvant temozolomide patient newly diagnose glioblastoma multiforme ( GBM ) .The anticipated time study treatment disease progression , target sample size 32 individual .</brief_summary>
	<brief_title>Efficacy Safety Atorvastatin Combination With Radiotherapy Temozolomide Glioblastoma</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Histologically proven newly diagnose Malignant Glioblastoma Multiforme variant ( gliosarcoma , glioblastoma oligodendroglial feature , giant cell glioblastoma ) . Age ≥ 18 year . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 2 . Patients must estimate life expectancy least 12 week . No prior chemotherapy radiotherapy . Stable dose steroid ≥ 14 day prior registration . Patients must adequate bone marrow function ( e.g. , hemoglobin ≥10 g/dl , absolute granulocyte count ≥ 1.5 x 109/L , platelet count ≥100 x 109/L . Adequate liver function ( SGPT , SGOT , alkaline phosphatase ≤ 2.5 time upper limit normal ( ULN ) total bilirubin ≤1.5 x ULN ) , adequate renal function ( BUN creatinine ≤1.5 X ULN ) prior start therapy . Paraffin embed tumour sample available study . Patient consent must obtain accord local Institutional requirement . The patient must sign consent form prior registration . Protocol treatment begin within 10 work day patient registration . Pregnant lactating woman ; men woman childbearing potential must agree practice effective method birth control . Women childbearing potential must negative pregnancy test perform within 14 day prior registration . Concurrent treatment experimental drug anticancer therapy . Patients history malignancy , except : adequately treat nonmelanoma skin cancer , curatively treated insitu cancer cervix , solid tumour curatively treat evidence disease &gt; 5 year . Prior radiotherapy systemic cytotoxic chemotherapy . Severe , active comorbidity , define follow : Acute bacterial fungal infection require intravenous antibiotic time registration , Chronic obstructive pulmonary disease exacerbation respiratory illness require hospitalization oxygen , Hepatic insufficiency Active liver disease result clinical jaundice and/or coagulation defect , Acquired immune deficiency syndrome ( AIDS ) , Significant neurologic psychiatric disorder would impair ability obtain informed consent , Active uncontrolled serious infection , active peptic ulcer disease , Any medical condition could interfere oral medication intake ( e.g. , frequent vomiting , partial bowel obstruction ) , Myocardial infarction within 6 month prior registration , Congestive heart failure , unstable angina , active cardiomyopathy , cardiac arrhythmia , Skeletal muscle disease relate reticuleendothelial disease . Patients know hypersensitivity study drug component .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Phase II</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Temozolomide</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Glioblastoma Multiforme ( GBM )</keyword>
</DOC>